Showing results (141-150 of 148) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
The Lancet. Oncology|June 23, 2015
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trialAndrew X Zhu, Joon Oh Park, Baek-Yeol Ryoo, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 24, 2005
A phase II trial of gemcitabine and weekly high-dose 5-fluorouracil in a 48-hour continuous-infusion schedule in patients with advanced pancreatic carcinoma. A study of the Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD)Joan Maurel Santasusana, José Luis García López, Juan José García, et al.ESMO Open|November 5, 2020
FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trialEnrique Aranda, Jose Maria Viéitez, Auxiliadora Gómez-España, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 9, 2025
Real-world management and outcomes of patients with hepatocellular carcinoma treated with systemic therapy in Spain: a patient cohort from the RETUD gastrointestinal registryCarlos López-López, Eva Martínez de Castro, Ana Fernández Montes, et al.The Oncologist|January 12, 2012
First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD studyEduardo Díaz-Rubio, Auxiliadora Gómez-España, Bartomeu Massutí, et al.Journal of the National Cancer Institute|January 27, 2017
Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer PatientsEnrique Gonzalez-Billalabeitia, Daniel Castellano, Nora Sobrevilla, et al.International Journal of Cancer|May 16, 2018
Whole exome sequencing identifies PLEC, EXO5 and DNAH7 as novel susceptibility genes in testicular cancerBeatriz Paumard-Hernández, Oriol Calvete, Lucia Inglada Pérez, et al.BMC Cancer|November 18, 2025
Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial designMercedes Salgado, Juan de la Camara-Gómez, Ignacio García-Escobar, et al.Pageof 15